Journal of Pediatric Epilepsy 2020; 9(03): 092-093
DOI: 10.1055/s-0040-1716486
Review Article

Impact of Nonclinical Factors on Treatment Decisions: What Can and Cannot Be Done and Why?

1  Departments of Pediatrics and Neurology, Division of Child Neurology, Medical Director, Pediatric Epilepsy Program, Primary Children's Hospital, Salt Lake City, University of Utah, Salt Lake City, Utah, United States
› Author Affiliations

Abstract

This clinical scenario describes a situation where drug-resistant focal epilepsy could have been treated with specific surgery, but a mixture of nonclinical factors led to a different management. The epilepsy started at the age of 6 years and the assessment for other treatment options by this team was done at the age of 12 years. Financial factors were important in the decisions that had to be made and effectively perhaps decisive.



Publication History

Received: 05 August 2020

Accepted: 05 August 2020

Publication Date:
18 September 2020 (online)

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Stuttgart · New York